Zobrazeno 1 - 10 of 252 pro vyhledávání: '"Mario M Alvarez"'
1
Akademický článek
An influenza A/H1N1/2009 hemagglutinin vaccine produced in Escherichia coli.
Autor: José M Aguilar-Yáñez, Roberto Portillo-Lara, Gonzalo I Mendoza-Ochoa, Sergio A García-Echauri, Felipe López-Pacheco, David Bulnes-Abundis, Johari Salgado-Gallegos, Itzel M Lara-Mayorga, Yenny Webb-Vargas, Felipe O León-Angel, Ramón E Rivero-Aranda, Yuriana Oropeza-Almazán, Guillermo M Ruiz-Palacios, Manuel I Zertuche-Guerra, Rebecca M DuBois, Stephen W White, Stacey Schultz-Cherry, Charles J Russell, Mario M Alvarez
Publikováno v: PLoS ONE, Vol 5, Iss 7, p e11694 (2010)
The A/H1N1/2009 influenza pandemic made evident the need for faster and higher-yield methods for the production of influenza vaccines. Platforms based on virus culture in mammalian or insect cells are currently under investigation. Alternatively, exp
Externí odkaz: https://doaj.org/article/92879a1591914b66b9e8aa1c5572aabf
Zobrazit plný text záznamu
2
Akademický článek
Specific recognition of influenza A/H1N1/2009 antibodies in human serum: a simple virus-free ELISA method.
Autor: Mario M Alvarez, Felipe López-Pacheco, José M Aguilar-Yañez, Roberto Portillo-Lara, Gonzalo I Mendoza-Ochoa, Sergio García-Echauri, Pamela Freiden, Stacey Schultz-Cherry, Manuel I Zertuche-Guerra, David Bulnes-Abundis, Johari Salgado-Gallegos, Leticia Elizondo-Montemayor, Martín Hernández-Torre
Publikováno v: PLoS ONE, Vol 5, Iss 4, p e10176 (2010)
BackgroundAlthough it has been estimated that pandemic Influenza A H1N1/2009 has infected millions of people from April to October 2009, a more precise figure requires a worldwide large-scale diagnosis of the presence of Influenza A/H1N1/2009 antibod
Externí odkaz: https://doaj.org/article/2395a043cdfb408b8861f05327c904c8
Zobrazit plný text záznamu
5
Towards foundational verification of cyber-physical systems
Autor: Sorin Lerner, Mario M. Alvarez, Gregory Malecha, Daniel Ricketts
Publikováno v: SOSCYPS@CPSWeek
The safety-critical aspects of cyber-physical systems motivate the need for rigorous analysis of these systems. In the literature this work is often done using idealized models of systems where the analysis can be carried out using high-level reasoni
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::811fc487f8465633c4fd383c94dd8eea
https://doi.org/10.1109/soscyps.2016.7580000
Zobrazit plný text záznamu
6
Towards verification of hybrid systems in a foundational proof assistant
Autor: Gregory Malecha, Sorin Lerner, Daniel Ricketts, Vignesh Gowda, Mario M. Alvarez
Publikováno v: MEMOCODE
Unsafe behavior of hybrid systems can have disastrous consequences, motivating the need for formal verification of the software running on these systems. Foundational verification in a proof assistant such as Coq is a promising technique that can pro
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e6dfbc48f91f43f816a0741ad0f537a5
https://doi.org/10.1109/memcod.2015.7340492
Zobrazit plný text záznamu
7
Akademický článek
Guardians at the Gate: Optimization of Small Molecule Entry Inhibitors of Ebola and Marburg Viruses.
Autor: Argade MD; UICentre: Drug Discovery, University of Illinois Chicago, Chicago, Illinois 60612, United States.; Department of Pharmaceutical Sciences, University of Illinois Chicago, Chicago, Illinois 60612, United States., Achi JG; Department of Microbiology and Immunology, University of Illinois Chicago, Chicago, Illinois 60612, United States., Bott R; Department of Microbiology and Immunology, University of Illinois Chicago, Chicago, Illinois 60612, United States., Morsheimer KM; Department of Virology, Immunology, and Microbiology, National Emerging Infectious Diseases Laboratories, Boston University Medical Campus, Boston, Massachusetts 02118, United States., Owen CD; Department of Virology, Immunology, and Microbiology, National Emerging Infectious Diseases Laboratories, Boston University Medical Campus, Boston, Massachusetts 02118, United States., Zielinski CA; UICentre: Drug Discovery, University of Illinois Chicago, Chicago, Illinois 60612, United States.; Department of Pharmaceutical Sciences, University of Illinois Chicago, Chicago, Illinois 60612, United States., Gaisin AM; UICentre: Drug Discovery, University of Illinois Chicago, Chicago, Illinois 60612, United States.; Department of Pharmaceutical Sciences, University of Illinois Chicago, Chicago, Illinois 60612, United States., Alvarez M; Department of Pharmaceutical Sciences, University of Illinois Chicago, Chicago, Illinois 60612, United States., Moore TW; Department of Pharmaceutical Sciences, University of Illinois Chicago, Chicago, Illinois 60612, United States., Bu F; Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota 55455, United States.; Center for Emerging Viruses, University of Minnesota, Minneapolis, Minnesota 55455, United States., Li F; Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota 55455, United States.; Center for Emerging Viruses, University of Minnesota, Minneapolis, Minnesota 55455, United States., Cameron M; Department of Molecular Medicine, Herbert Wertheim, UF Scripps Institute for Biomedical Innovation and Technology, Jupiter, Florida 33458, United States., Anantpadma M; The Integrated Research Facility, National Institute of Allergy and Infectious Diseases, Frederick, Maryland 20892, United States., Davey RA; Department of Virology, Immunology, and Microbiology, National Emerging Infectious Diseases Laboratories, Boston University Medical Campus, Boston, Massachusetts 02118, United States., Peet NP; Chicago BioSolutions Inc., Chicago, Illinois 60612, United States., Rong L; Department of Microbiology and Immunology, University of Illinois Chicago, Chicago, Illinois 60612, United States.; Chicago BioSolutions Inc., Chicago, Illinois 60612, United States., Gaisina IN; UICentre: Drug Discovery, University of Illinois Chicago, Chicago, Illinois 60612, United States.; Department of Pharmaceutical Sciences, University of Illinois Chicago, Chicago, Illinois 60612, United States.; Chicago BioSolutions Inc., Chicago, Illinois 60612, United States.
Publikováno v: Journal of medicinal chemistry [J Med Chem] 2024 Dec 16. Date of Electronic Publication: 2024 Dec 16.
Zobrazit plný text záznamu
8
Akademický článek
Unlocking the Potential of Adequate Bacillus Calmette-Guérin Immunotherapy in Very-high-risk Non-muscle-invasive Bladder Carcinoma: A Multicenter Analysis of Oncological Outcomes and Risk Dynamics.
Autor: Subiela JD; Department of Urology, Hospital Universitario Ramón y Cajal, IRYCIS, Universidad de Alcala, Madrid, Spain. Electronic address: jdsubiela@gmail.com., Krajewski W; Department of Minimally Invasive Robotic Urology, Center of Excellence in Urology, Wrocław Medical University, Wrocław, Poland., González-Padilla DA; Department of Urology, Clínica Universidad de Navarra, Madrid, Spain., Laszkiewicz J; Department of Minimally Invasive Robotic Urology, Center of Excellence in Urology, Wrocław Medical University, Wrocław, Poland., Taborda J; Department of Urology, Hospital Universitario Ramón y Cajal, IRYCIS, Universidad de Alcala, Madrid, Spain., Aumatell J; Servicio de Urología, Hospital Universitario Rey Juan Carlos, Universidad Rey Juan Carlos Móstoles, Madrid, Spain., Sanchez Encinas M; Servicio de Urología, Hospital Universitario Rey Juan Carlos, Universidad Rey Juan Carlos Móstoles, Madrid, Spain., Basile G; Division of Experimental Oncology, Department of Urology, Urological Research Institute, Vita-Salute San Raffaele University, Milan, Italy., Moschini M; Division of Experimental Oncology, Department of Urology, Urological Research Institute, Vita-Salute San Raffaele University, Milan, Italy., Caño-Velasco J; Department of Urology, Hospital Universitario Gregorio Marañon, Madrid, Spain., Lopez Perez E; Department of Urology, Hospital Universitario Ramón y Cajal, IRYCIS, Universidad de Alcala, Madrid, Spain., Del Olmo Durán P; Department of Urology, Hospital Universitario Ramón y Cajal, IRYCIS, Universidad de Alcala, Madrid, Spain., Gallioli A; Department of Urology, Fundaciò Puigvert, Autonomous University of Barcelona, Barcelona, Spain., Tukiendorf A; Institute of Health Sciences, Opole University, Opole, Poland; University Clinical Hospital in Opole, Opole, Poland., D'Andrea D; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Yuen-Chun Teoh J; S.H. Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Shatin, Hong Kong Special Administrative Region., Serna Céspedes A; Department of Urology, Hospital Universitario Ramón y Cajal, IRYCIS, Universidad de Alcala, Madrid, Spain., Pichler R; Medical University of Innsbruck, Department of Urology, Comprehensive Cancer Center Innsbruck (CCCI), Innsbruck, Austria., Afferi L; Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland., Del Giudice F; Department of Maternal-Infant and Urological Sciences, Policlinico Umberto I Hospital, 'Sapienza' University of Rome, Rome, Italy., Gomez Rivas J; Department of Urology, Hospital Clínico San Carlos, Madrid, Spain., Albisinni S; Urology Unit, Department of Surgical Sciences, Tor Vergata University Hospital, University of Rome Tor Vergata, Rome, Italy., Soria F; Division of Urology, Department of Surgical Sciences Molinette Hospital University of Torino School of Medicine, Torino, Italy., Ploussard G; Department of Urology, La Croix du Sud Hospital, Quint Fonsegrives, France., Mertens LS; Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Rajwa P; Department of Urology, Medical University of Silesia, Zabrze, Poland., Laukhtina E; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia., Pradere B; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, La Croix du Sud Hospital, Quint Fonsegrives, France., Tully K; Department of Urology and Neurourology, Marien Hospital Herne, Ruhr-University Bochum, Herne, Germany., Guerrero-Ramos F; Department of Urology, Hospital Universitario 12 de Octubre, Madrid, Spain; ROC Clinic, Madrid, Spain; Department of Urology, Hospital Universitario HM Sanchinarro, Madrid, Spain., Rodríguez-Faba Ó; Department of Urology, Fundaciò Puigvert, Autonomous University of Barcelona, Barcelona, Spain., Alvarez-Maestro M; Department of Urology, Hospital Universitario La Paz, Madrid, Spain., Dominguez-Escrig JL; Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain., Szydełko T; Department of Minimally Invasive Robotic Urology, Center of Excellence in Urology, Wrocław Medical University, Wrocław, Poland., Gomez Dos Santos V; Department of Urology, Hospital Universitario Ramón y Cajal, IRYCIS, Universidad de Alcala, Madrid, Spain., Jiménez Cidre MÁ; Department of Urology, Hospital Universitario Ramón y Cajal, IRYCIS, Universidad de Alcala, Madrid, Spain., Burgos Revilla FJ; Department of Urology, Hospital Universitario Ramón y Cajal, IRYCIS, Universidad de Alcala, Madrid, Spain.
Publikováno v: European urology oncology [Eur Urol Oncol] 2024 Dec; Vol. 7 (6), pp. 1367-1375. Date of Electronic Publication: 2024 Feb 13.
Zobrazit plný text záznamu
9
Akademický článek
The liminal space of first-episode psychosis and its treatment: A qualitative study exploring the experience of young people participating in an antipsychotic dose reduction randomized controlled trial.
Autor: Gates J; Orygen., Ellinghaus C; Orygen., Valentine L; Orygen., Kamitsis I; Orygen., Stainton A; Orygen., Harrigan S; Centre for Mental Health, Melbourne School of Population and Global Health, University of Melbourne., Thompson A; Orygen., Alvarez-Jimenez M; Orygen., Wood S; Orygen., Polari A; Orygen., Gleeson JF; Healthy Brain and Mind Research Centre, Australian Catholic University., Bartholomeusz C; Orygen., Allott K; Orygen., Killackey E; Orygen., Bendall S; Orygen.
Publikováno v: Psychiatric rehabilitation journal [Psychiatr Rehabil J] 2024 Dec; Vol. 47 (4), pp. 313-321. Date of Electronic Publication: 2024 Jul 18.
Zobrazit plný text záznamu
10
Akademický článek
A Personalized, Transdiagnostic Smartphone App (Mello) Targeting Repetitive Negative Thinking for Depression and Anxiety: Qualitative Analysis of Young People's Experience.
Autor: Valentine L; Orygen, Melbourne, Australia.; Orygen, Parkville, Australia., Arnold C; Orygen, Parkville, Australia., Nicholas J; Orygen, Melbourne, Australia.; Orygen, Parkville, Australia., Castagnini E; Orygen, Melbourne, Australia.; Orygen, Parkville, Australia., Malouf J; Orygen, Parkville, Australia., Alvarez-Jimenez M; Orygen, Melbourne, Australia.; Orygen, Parkville, Australia., Bell IH; Orygen, Melbourne, Australia.; Orygen, Parkville, Australia.
Publikováno v: Journal of medical Internet research [J Med Internet Res] 2024 Nov 27; Vol. 26, pp. e63732. Date of Electronic Publication: 2024 Nov 27.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje